A detailed history of China Universal Asset Management Co., Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,120 shares of COLL stock, worth $198,043. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,120
Previous 6,120 -0.0%
Holding current value
$198,043
Previous $238,000 0.42%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$31.23 - $40.91 $73,203 - $95,893
2,344 Added 62.08%
6,120 $238,000
Q4 2023

May 21, 2024

SELL
$21.16 - $30.8 $49,599 - $72,195
-2,344 Reduced 38.3%
3,776 $116,000
Q4 2023

Jan 23, 2024

BUY
$21.16 - $30.8 $60,877 - $88,611
2,877 Added 320.02%
3,776 $116,000
Q3 2023

May 21, 2024

BUY
$21.23 - $24.28 $9,447 - $10,804
445 Added 98.02%
899 $20,000
Q3 2023

Oct 30, 2023

BUY
$21.23 - $24.28 $9,447 - $10,804
445 Added 98.02%
899 $20,000
Q2 2023

May 21, 2024

SELL
$21.06 - $24.0 $168 - $192
-8 Reduced 1.73%
454 $9,000
Q2 2023

Jul 27, 2023

SELL
$21.06 - $24.0 $168 - $192
-8 Reduced 1.73%
454 $10,000
Q1 2023

May 21, 2024

BUY
$23.0 - $29.88 $2,783 - $3,615
121 Added 35.48%
462 $11,000
Q1 2023

Apr 27, 2023

BUY
$23.0 - $29.88 $2,783 - $3,615
121 Added 35.48%
462 $11,000
Q4 2022

May 21, 2024

SELL
$16.14 - $23.55 $93,273 - $136,095
-5,779 Reduced 94.43%
341 $7,000
Q4 2022

Jan 31, 2023

BUY
$16.14 - $23.55 $338 - $494
21 Added 6.56%
341 $8,000
Q3 2022

Oct 21, 2022

BUY
$15.46 - $20.1 $4,947 - $6,432
320 New
320 $5,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.1B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.